Nifty
:
19523.55
Sensex
:
65508.32
-192.90 (-0.98%)
-610.37 (-0.92%)
Nifty
Sensex
:
:
19523.55
65508.32
-192.90 (-0.98%)
-610.37 (-0.92%)

Lincoln Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

Rating :
69/99

BSE: 531633 | NSE: LINCOLN

NSE BSE
506.30
28-Sep-2023
  • Open
  • High
  • Low
  • Previous Close
  •  510.00
  •  511.60
  •  502.00
  •  506.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  30621
  •  155.41
  •  543.25
  •  275.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,014.41
  • 13.18
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 997.65
  • 0.30%
  • 1.94

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 48.67%
  • 4.29%
  • 37.32%
  • FII
  • DII
  • Others
  • 1.74%
  • 0.00%
  • 7.98%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.26
  • 5.54
  • 6.90

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.95
  • 12.79
  • 7.82

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.79
  • 14.91
  • 10.48

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.20
  • 8.78
  • 9.63

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.70
  • 1.45
  • 1.53

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.01
  • 6.01
  • 6.37

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Net Sales
135.62
123.47
9.84%
112.46
102.59
9.62%
133.77
119.88
11.59%
140.61
127.47
10.31%
Expenses
114.90
106.56
7.83%
95.82
85.14
12.54%
107.01
96.43
10.97%
111.71
98.20
13.76%
EBITDA
20.72
16.91
22.53%
16.64
17.45
-4.64%
26.75
23.45
14.07%
28.90
29.27
-1.26%
EBIDTM
15.28%
13.70%
14.80%
17.01%
20.00%
19.56%
20.55%
22.96%
Other Income
7.69
6.50
18.31%
3.90
1.89
106.35%
6.36
2.64
140.91%
5.72
3.46
65.32%
Interest
0.42
0.41
2.44%
1.15
0.57
101.75%
0.33
0.31
6.45%
0.14
0.20
-30.00%
Depreciation
2.54
2.07
22.71%
2.41
2.00
20.50%
2.26
2.18
3.67%
2.42
1.99
21.61%
PBT
25.45
20.93
21.60%
16.98
16.77
1.25%
30.52
23.60
29.32%
32.06
30.54
4.98%
Tax
6.43
5.91
8.80%
4.42
5.75
-23.13%
8.90
6.00
48.33%
8.35
7.51
11.19%
PAT
19.01
15.01
26.65%
12.56
11.03
13.87%
21.61
17.60
22.78%
23.71
23.03
2.95%
PATM
14.02%
12.16%
11.17%
10.75%
16.16%
14.68%
16.86%
18.06%
EPS
9.49
7.49
26.70%
6.27
5.50
14.00%
10.79
8.79
22.75%
11.84
11.50
2.96%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
522.46
472.12
424.19
386.49
366.15
360.61
360.26
400.15
266.07
210.49
194.70
Net Sales Growth
10.36%
11.30%
9.75%
5.56%
1.54%
0.10%
-9.97%
50.39%
26.41%
8.11%
 
Cost Of Goods Sold
243.86
169.71
155.86
138.15
135.66
156.44
202.90
254.64
161.12
123.72
113.96
Gross Profit
278.60
302.41
268.32
248.34
230.49
204.18
157.35
145.50
104.96
86.77
80.74
GP Margin
53.33%
64.05%
63.25%
64.26%
62.95%
56.62%
43.68%
36.36%
39.45%
41.22%
41.47%
Total Expenditure
429.44
376.64
337.01
320.95
298.91
308.30
313.52
359.62
240.47
190.42
179.22
Power & Fuel Cost
-
8.33
7.10
8.18
7.21
6.82
5.92
5.68
4.27
3.40
2.12
% Of Sales
-
1.76%
1.67%
2.12%
1.97%
1.89%
1.64%
1.42%
1.60%
1.62%
1.09%
Employee Cost
-
70.47
63.26
58.65
51.90
51.15
37.59
28.83
17.87
18.57
17.71
% Of Sales
-
14.93%
14.91%
15.18%
14.17%
14.18%
10.43%
7.20%
6.72%
8.82%
9.10%
Manufacturing Exp.
-
69.33
61.54
64.05
60.71
51.73
29.44
35.81
25.98
19.10
17.54
% Of Sales
-
14.68%
14.51%
16.57%
16.58%
14.35%
8.17%
8.95%
9.76%
9.07%
9.01%
General & Admin Exp.
-
28.48
23.06
21.30
20.98
17.50
14.78
20.34
18.86
15.07
13.25
% Of Sales
-
6.03%
5.44%
5.51%
5.73%
4.85%
4.10%
5.08%
7.09%
7.16%
6.81%
Selling & Distn. Exp.
-
27.82
24.54
26.79
20.02
21.24
19.91
10.10
9.42
8.42
13.22
% Of Sales
-
5.89%
5.79%
6.93%
5.47%
5.89%
5.53%
2.52%
3.54%
4.00%
6.79%
Miscellaneous Exp.
-
2.50
1.64
3.83
2.43
3.44
2.97
4.22
2.95
2.13
13.22
% Of Sales
-
0.53%
0.39%
0.99%
0.66%
0.95%
0.82%
1.05%
1.11%
1.01%
0.73%
EBITDA
93.01
95.48
87.18
65.54
67.24
52.31
46.74
40.53
25.60
20.07
15.48
EBITDA Margin
17.80%
20.22%
20.55%
16.96%
18.36%
14.51%
12.97%
10.13%
9.62%
9.53%
7.95%
Other Income
23.67
10.00
5.66
11.04
5.63
5.45
2.78
7.36
7.19
2.49
6.40
Interest
2.04
1.45
1.56
2.02
4.00
5.41
6.66
9.96
8.38
6.97
7.84
Depreciation
9.63
8.09
7.56
7.33
6.68
6.11
5.51
4.87
4.57
3.53
2.65
PBT
105.01
95.94
83.72
67.23
62.19
46.25
37.33
33.07
19.85
12.07
11.38
Tax
28.10
26.58
21.47
15.77
13.46
11.60
9.20
9.27
4.80
1.89
1.85
Tax Rate
26.76%
27.70%
25.65%
23.46%
21.64%
25.08%
24.65%
28.03%
24.18%
15.66%
16.26%
PAT
76.89
69.36
62.25
51.44
48.71
34.62
28.12
23.68
15.01
10.65
9.66
PAT before Minority Interest
76.89
69.36
62.25
51.47
48.74
34.65
28.13
23.80
15.04
10.18
9.53
Minority Interest
0.00
0.00
0.00
-0.03
-0.03
-0.03
-0.01
-0.12
-0.03
0.47
0.13
PAT Margin
14.72%
14.69%
14.68%
13.31%
13.30%
9.60%
7.81%
5.92%
5.64%
5.06%
4.96%
PAT Growth
15.33%
11.42%
21.01%
5.60%
40.70%
23.12%
18.75%
57.76%
40.94%
10.25%
 
EPS
38.45
34.68
31.13
25.72
24.36
17.31
14.06
11.84
7.51
5.33
4.83

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
432.88
366.39
313.09
269.34
224.22
192.38
140.52
111.31
98.81
89.30
Share Capital
20.03
20.03
20.00
20.00
20.00
20.00
16.31
16.31
16.31
16.31
Total Reserves
412.85
346.36
293.09
249.34
204.22
172.38
116.65
95.00
82.50
72.99
Non-Current Liabilities
10.99
26.10
42.85
28.43
24.94
31.75
33.74
33.14
26.18
25.14
Secured Loans
0.00
0.14
0.85
1.69
6.93
12.38
23.62
15.27
16.20
14.41
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
10.21
3.04
2.66
Long Term Provisions
0.00
15.98
32.51
17.49
7.19
9.98
0.00
0.00
0.00
0.00
Current Liabilities
110.71
94.78
80.32
100.37
113.48
99.42
100.34
114.47
131.05
118.26
Trade Payables
71.66
57.07
51.24
44.01
43.42
32.46
30.38
45.31
66.51
47.51
Other Current Liabilities
9.85
13.43
9.13
11.11
11.11
12.77
15.10
11.52
14.15
15.57
Short Term Borrowings
2.04
0.00
3.83
30.09
48.55
45.04
52.62
50.67
48.46
54.90
Short Term Provisions
27.16
24.28
16.11
15.16
10.41
9.15
2.24
6.97
1.92
0.27
Total Liabilities
554.58
487.27
436.64
398.50
362.97
323.85
274.79
261.85
259.75
236.88
Net Block
131.88
110.64
122.72
120.91
116.58
102.71
98.47
65.62
65.07
64.94
Gross Block
171.07
141.90
146.70
138.11
127.65
108.16
120.89
87.50
82.22
78.82
Accumulated Depreciation
39.19
31.26
23.98
17.21
11.08
5.45
22.42
21.88
17.15
13.89
Non Current Assets
181.51
159.59
173.91
159.43
136.08
134.27
127.83
80.64
110.69
113.67
Capital Work in Progress
16.05
1.69
0.04
2.10
0.29
6.63
2.73
2.55
2.37
2.37
Non Current Investment
0.00
0.00
0.09
0.09
0.09
0.09
0.01
0.01
0.41
0.41
Long Term Loans & Adv.
31.83
46.81
51.02
36.01
18.79
24.48
26.62
12.47
42.84
45.95
Other Non Current Assets
1.75
0.45
0.03
0.33
0.34
0.36
0.00
0.00
0.00
0.00
Current Assets
373.07
327.69
262.73
239.08
226.88
189.58
146.98
181.20
149.06
123.21
Current Investments
96.81
80.66
34.22
18.07
10.97
10.25
0.00
0.00
0.00
0.00
Inventories
72.74
46.61
47.40
36.23
45.41
37.31
27.48
21.82
23.84
19.33
Sundry Debtors
115.94
113.35
101.34
122.47
109.44
90.67
80.53
119.01
89.04
74.79
Cash & Bank
18.80
13.84
14.58
7.58
14.59
11.68
12.66
11.51
10.45
15.15
Other Current Assets
68.78
1.43
1.11
1.10
46.47
39.68
26.31
28.86
25.73
13.94
Short Term Loans & Adv.
67.35
71.79
64.09
53.64
45.18
39.02
26.26
28.86
25.73
13.94
Net Current Assets
262.36
232.91
182.41
138.71
113.40
90.16
46.63
66.73
18.01
4.95
Total Assets
554.58
487.28
436.64
398.51
362.96
323.85
274.81
261.84
259.75
236.88

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
76.13
69.27
75.42
52.84
26.63
25.04
44.80
24.56
4.64
-15.60
PBT
95.94
83.72
67.23
62.19
46.25
37.33
33.07
19.85
12.07
9.53
Adjustment
1.48
4.84
8.66
9.30
11.64
10.70
13.75
10.68
12.75
8.96
Changes in Working Capital
2.41
0.20
14.33
-1.12
-22.00
-13.24
4.80
-2.50
-17.56
-32.36
Cash after chg. in Working capital
99.83
88.76
90.22
70.38
35.88
34.79
51.62
28.02
7.26
-13.87
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-23.70
-19.49
-14.81
-17.53
-9.25
-9.75
-6.82
-3.46
-2.62
-1.73
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-78.08
-64.23
-30.88
-18.19
-11.77
-25.48
-41.79
6.52
1.45
-16.27
Net Fixed Assets
-43.53
-35.54
-5.59
-11.52
-12.45
4.05
-29.04
-4.21
-0.95
-2.89
Net Investments
-16.15
-20.70
-14.20
-7.10
-2.72
-16.01
-7.34
-1.43
0.00
0.00
Others
-18.40
-7.99
-11.09
0.43
3.40
-13.52
-5.41
12.16
2.40
-13.38
Cash from Financing Activity
-2.56
-5.75
-37.76
-35.77
-11.41
0.30
-3.42
-32.04
-10.51
29.30
Net Cash Inflow / Outflow
-4.50
-0.70
6.77
-1.11
3.45
-0.14
-0.41
-0.96
-4.42
-2.57
Opening Cash & Equivalents
11.44
12.14
5.46
6.57
3.12
3.26
3.75
4.82
9.39
11.97
Closing Cash & Equivalent
6.93
11.44
12.23
5.46
6.57
3.12
3.43
3.87
4.97
9.39

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
216.12
182.92
156.54
134.67
112.11
96.19
81.52
68.24
60.58
54.75
ROA
13.31%
13.48%
12.33%
12.80%
10.09%
9.40%
8.87%
5.77%
4.10%
4.25%
ROE
17.35%
18.32%
17.67%
19.75%
16.63%
17.29%
19.49%
14.32%
10.83%
11.21%
ROCE
24.29%
24.90%
22.30%
22.50%
19.05%
18.51%
21.18%
15.91%
11.48%
12.21%
Fixed Asset Turnover
3.17
3.04
2.81
2.84
3.07
3.19
3.90
3.20
2.67
3.10
Receivable days
84.27
89.34
102.22
112.23
100.99
85.52
89.69
139.97
139.16
128.96
Inventory Days
43.86
39.12
38.19
39.51
41.74
32.36
22.16
30.72
36.67
37.48
Payable days
138.43
126.82
56.60
57.26
47.62
37.21
40.22
92.31
115.76
98.21
Cash Conversion Cycle
-10.29
1.64
83.82
94.48
95.11
80.67
71.63
78.37
60.06
68.23
Total Debt/Equity
0.00
0.00
0.02
0.12
0.27
0.34
0.59
0.69
0.69
0.85
Interest Cover
67.11
54.61
34.32
16.56
9.55
6.60
4.32
3.37
2.73
2.45

Annual Reports:

FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013

News Update:


  • Lincoln Pharma - Quarterly Results
    10th Aug 2023, 12:22 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.